GE HealthCare misses Q1 EPS but tops revenue estimates as Imaging, AVS and PDx growth offset PCS weakness; shares slide due to margin pressure.
GE Healthcare Technologies Inc (NASDAQ:GEHC) shares fell sharply on Wednesday after the medical imaging company reported first-quarter earnings that missed Wall Street expectations and trimmed its full-year profit and margin outlook, citing supply chain pressures and elevated costs. Shares were down approximately 12.8% in morning trading.
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $0.99 per share, missing the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.01 per share a year ago.
GE HealthCare doses first patient in Phase 2/3 LUMINA trial for mangaciclanol, a manganese MRI contrast agent with FDA Fast Track status.
GEHC heads into Q1 earnings with steady demand and a $21.8B backlog, but China weakness and tariff costs may weigh on growth and margins.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
GE HealthCare teams with Medtronic to integrate real-time imaging in cranial surgery, aiming to enhance precision, workflows and clinician decision-making.
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
GE HealthCare (GEHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Abbott (ABT). But which of these two stocks is more attractive to value investors?